158 related articles for article (PubMed ID: 1777583)
1. Drug-DNA interactions: spectroscopic and footprinting studies of site and sequence specificity of elliptinium.
Mauffret O; Rene B; Convert O; Monnot M; Lescot E; Fermandjian S
Biopolymers; 1991 Oct; 31(11):1325-41. PubMed ID: 1777583
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic studies of 9-hydroxyellipticine binding to DNA.
Ismail MA; Sanders KJ; Fennell GC; Latham HC; Wormell P; Rodger A
Biopolymers; 1998 Sep; 46(3):127-43. PubMed ID: 9741963
[TBL] [Abstract][Full Text] [Related]
3. The interaction of ellipticine derivatives with nucleic acids studied by optical and 1H-nmr spectroscopy: effect of size of the heterocyclic ring system.
Behravan G; Leijon M; Sehlstedt U; Nordén B; Vallberg H; Bergman J; Gräslund A
Biopolymers; 1994 May; 34(5):599-609. PubMed ID: 8003620
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of drug-DNA interactions: a comparative temperature jump study of ellipticinium and 9-hydroxy ellipticinium.
Schwaller MA; Aubard J; Dodin G
J Biomol Struct Dyn; 1988 Dec; 6(3):443-58. PubMed ID: 3271531
[TBL] [Abstract][Full Text] [Related]
5. The anticancer agent ellipticine unwinds DNA by intercalative binding in an orientation parallel to base pairs.
Canals A; Purciolas M; Aymamí J; Coll M
Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):1009-12. PubMed ID: 15983425
[TBL] [Abstract][Full Text] [Related]
6. Probing intercalation and conformational effects of the anticancer drug 2-methyl-9-hydroxyellipticinium acetate in DNA fragments with circular dichroism.
Monnot M; Mauffret O; Lescot E; Fermandjian S
Eur J Biochem; 1992 Mar; 204(3):1035-9. PubMed ID: 1551384
[TBL] [Abstract][Full Text] [Related]
7. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
Franklin SJ; Barton JK
Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
[TBL] [Abstract][Full Text] [Related]
8. Molecular recognition between oligopeptides and nucleic acids. Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H NMR studies.
Lee M; Krowicki K; Shea RG; Lown JW; Pon RT
J Mol Recognit; 1989 Sep; 2(2):84-93. PubMed ID: 2561528
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; Braña MF; Bailly C
Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
[TBL] [Abstract][Full Text] [Related]
10. Solution conformation of the (-)-cis-anti-benzo[a]pyrenyl-dG adduct opposite dC in a DNA duplex: intercalation of the covalently attached BP ring into the helix with base displacement of the modified deoxyguanosine into the major groove.
Cosman M; Hingerty BE; Luneva N; Amin S; Geacintov NE; Broyde S; Patel DJ
Biochemistry; 1996 Jul; 35(30):9850-63. PubMed ID: 8703959
[TBL] [Abstract][Full Text] [Related]
11. Preferred binding sites for the bifunctional intercalator TANDEM determined using DNA fragments that contain every symmetrical hexanucleotide sequence.
Hampshire AJ; Fox KR
Anal Biochem; 2008 Mar; 374(2):298-303. PubMed ID: 17980140
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin D binding to single-stranded DNA: sequence specificity and hemi-intercalation model from fluorescence and 1H NMR spectroscopy.
Wadkins RM; Jares-Erijman EA; Klement R; Rüdiger A; Jovin TM
J Mol Biol; 1996 Sep; 262(1):53-68. PubMed ID: 8809179
[TBL] [Abstract][Full Text] [Related]
13. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
[TBL] [Abstract][Full Text] [Related]
14. 1H- and 31P-NMR studies of ditercalinium binding to a d(GCGC)2 and d(CCTATAGG)2 minihelices: a sequence specificity study.
Delepierre M; Milhe C; Namane A; Dinh TH; Roques BP
Biopolymers; 1991 Feb; 31(3):331-53. PubMed ID: 1868161
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the actions of drugs that bind in the DNA minor groove.
Albert FG; Eckdahl TT; Fitzgerald DJ; Anderson JN
Biochemistry; 1999 Aug; 38(31):10135-46. PubMed ID: 10433722
[TBL] [Abstract][Full Text] [Related]
16. Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.
Sissi C; Capranico G; Menta E; Palumbo M
Mol Pharmacol; 1996 Oct; 50(4):838-45. PubMed ID: 8863828
[TBL] [Abstract][Full Text] [Related]
17. Peroxidase-catalyzed covalent binding of the antitumor drug N2-methyl-9-hydroxyellipticinium to DNA in vitro.
Auclair C; Dugué B; Meunier B; Paoletti C
Biochemistry; 1986 Mar; 25(6):1240-5. PubMed ID: 3964674
[TBL] [Abstract][Full Text] [Related]
18. Monitoring anthracycline binding to nucleotides by two dimensional cosy NMR experiments.
Hammer BC; Russell RA; Warrener RN; Collins JG
Biochem Int; 1991 Aug; 24(6):1075-84. PubMed ID: 1781786
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of the binding of the diquaternary pyridophenazine derivative dqdppn to B-DNA oligonucleotides.
Waywell P; Thomas JA; Williamson MP
Org Biomol Chem; 2010 Feb; 8(3):648-54. PubMed ID: 20090983
[TBL] [Abstract][Full Text] [Related]
20. Theoretical design, chemical synthesis and footprinting analysis of a novel peptide derivative of the intercalator 7-H pyridocarbazole targeted towards the major groove of DNA.
Gresh N; René B; Hui XW; Barsi MC; Roques BP; Garbay C
J Biomol Struct Dyn; 1994 Aug; 12(1):091-110. PubMed ID: 7848561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
